FDA Adverse Event Malfunction Summary report: N

LOBO VASCULAR OCCLUSION SYSTEM

MDR report key: 24613622 · Received March 16, 2026

Report

Report Number
3016444913-2026-00007
Event Type
Malfunction
Date Received
March 16, 2026
Date of Event
April 25, 2023
Report Date
March 16, 2026
Manufacturer
OKAMI MEDICAL INC.
Product Code
KRD
PMA / PMN Number
K192083
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE PHYSICIAN DECIDED TO USE TWO MORE DOSES OF #9 PARTICLES. HE THEN PLACED A SECOND LOBO-3 PROXIMALLY WHICH WAS ALSO IMMEDIATELY OCCLUSIVE. THE PHYSICIAN ASSESSED THE DEVICE POSITION AND ELECTED TO LEAVE IT IN PLACE AS IT WAS PERFORMING ITS INTENDED FUNCTION TO OBSTRUCT OR REDUCE FLOW IN THE ARTERY AND DID NOT POSE A SAFETY RISK. NO FURTHER FOLLOW-UP WAS REQUIRED AS DETERMINED BY THE PHYSICIAN. MOVEMENT OF THE DEVICE WAS ATTRIBUTED TO USE ERROR, WHERE THE PHYSICIAN DID NOT FOLLOW THE LABELED INSTRUCTIONS FOR USE ("ENSURE THE TARGETED VESSEL MEETS THE RECOMMENDED DIAMETER") AND PROCEEDED TO PLACE LOBO-3 IN A 3.1 MM VESSEL, ABOVE THE LABELED USE VESSEL DIAMETER RANGE OF 1.5 TO 3.0 MM. THE DEVICE WAS NOT RETURNED FOR EVALUATION, AND NO LOT NUMBER WAS PROVIDED; THEREFORE, NO INVESTIGATION COULD BE CONDUCTED.

Description of Event or Problem · 0

IT WAS REPORTED THAT A PATIENT WITH A VERY LARGE UTERINE FIBROID UNDERWENT UTERINE ARTERY EMBOLIZATION. THE TREATMENT PLAN INCLUDED EMBOLIZATION WITH PARTICLES FOLLOWED BY VESSEL OCCLUSION USING A LOBO-3 DEVICE. THE UTERINE ARTERIES WERE NOTED TO BE UNUSUALLY LARGE AND EXTREMELY TORTUOUS. IN THE FIRST ARTERY, PARTICLES (#5 AND #7) WERE INJECTED, AND A LOBO-3 DEVICE WAS DEPLOYED IN A VESSEL MEASURED AT APPROXIMATELY 3.1 MM. THE DEVICE MIGRATED APPROXIMATELY 13 MM AFTER PLACEMENT BUT WAS IMMEDIATELY OCCLUSIVE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
675077 LOBO VASCULAR OCCLUSION SYSTEM VASCULAR EMBOLIZATION DEVICE KRD OKAMI MEDICAL INC. LOBO-3

Patients

Seq Age Sex Outcome Treatment
1 46 YR Female Other